A new model for translational regulation of specific mRNAs

Trends in Biochemical Sciences

Volumn 31, Issue 11, 2006, Pages 607-610

  Tettweiler, Gritta ^a   Lasko, Paul ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; RETROVIRUS VECTOR; RNA HELICASE;

HUMAN; MOLECULAR RECOGNITION; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN STRUCTURE; REGULATORY MECHANISM; RNA TRANSLATION; SHORT SURVEY; TRANSCRIPTION INITIATION; TRANSLATION INITIATION;

MODELS, GENETIC; PROTEIN BIOSYNTHESIS; RNA, MESSENGER;

EID: 33750296445     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2006.09.008     Document Type: Short Survey

References (19)

1. Sonenberg N., et al. Translational control of gene expression (2000), Cold Spring Harbor Laboratory Press
2. Pelletier J., and Sonenberg N. Insertion mutagenesis to increase secondary structure within the 5′ noncoding region of a eukaryotic mRNA reduces translational efficiency. Cell 40 (1985) 515-526
3. Butsch M., et al. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production. J. Virol. 73 (1999) 4847-4855
4. Roberts T.M., and Boris-Lawrie K. Primary sequence and secondary structure motifs in spleen necrosis virus RU5 confer translational utilization of unspliced human immunodeficiency virus type 1 reporter RNA. J. Virol. 77 (2003) 11973-11984
5. Roberts Hartman T., et al. RNA helicase A is necessary for translation of selected messenger RNAs. Nat. Struct. Mol. Biol. 13 (2006) 509-516
6. Hull S., and Boris-Lawrie K. RU5 of Mason-Pfizer monkey virus 5′ long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA. J. Virol. 76 (2002) 10211-10218
7. Tang H., et al. The carboxyl terminus of RNA helicase A contains a bidirectional nuclear transport domain. Mol. Cell. Biol. 19 (1999) 3540-3550
8. Lee C.G., and Hurwitz J. A new RNA helicase isolated from HeLa cells that catalytically translocates in the 3′ to 5′ direction. J. Biol. Chem. 267 (1992) 4398-4407
9. Cordin O., et al. The DEAD-box protein family of RNA helicases. Gene 367 (2006) 17-37
10. Zhang S., and Grosse F. Domain structure of human nuclear DNA helicase II (RNA helicase A). J. Biol. Chem. 272 (1997) 11487-11494
11. Gamberi C., et al. Drosophila RNA binding proteins. Int. Rev. Cytol. 248 (2006) 43-139
12. Johnstone O., and Lasko P. Translational regulation and RNA localization in Drosophila oocytes and embryos. Annu. Rev. Genet. 35 (2001) 365-406
13. Svitkin Y.V., et al. The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure. RNA 7 (2001) 382-394
14. Yilmaz A., et al. Coordinate enhancement of transgene transcription and translation in a lentiviral vector. Retrovirology 3 (2006) 13
15. Dangel A.W., et al. Nuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5. J. Virol. 76 (2002) 3292-3300
16. ts, a mutation affecting sodium channel activity in Drosophila, is an allele of mle, a regulator of X chromosome transcription. Cell 66 (1991) 949-959
17. Kuroda M.I., et al. The maleless protein associates with the X chromosome to regulate dosage compensation in Drosophila. Cell 66 (1991) 935-947
18. Bashaw G.J., and Baker B.S. Dosage compensation and chromatin structure in Drosophila. Curr. Opin. Genet. Dev. 6 (1996) 496-501
19. Roy B.B., et al. Association of RNA helicase a with human immunodeficiency virus type 1 particles. J. Biol. Chem. 281 (2006) 12625-12635